Headline
The latest stories from AHA Today.
The Centers for Medicare & Medicaid Services released an updated snapshot of the impact of COVID-19 on the Medicare population, which includes COVID-19 cases and hospitalizations through June 20 and the first data for American Indian/Alaskan Native Medicare beneficiaries.
The National Association of Medicaid Directors asked the Centers for Medicare & Medicaid Services to suspend finalizing the Medicaid Fiscal Accountability Rule while states respond to the COVID-19 pandemic and its impact on state budgets.
Senate Republicans released a series of bills aimed at addressing the COVID-19 pandemic.
The AHA announced it is honoring five hospital-led partnerships with the AHA Dick Davidson NOVA Award for each program’s efforts to improve community health.
President Trump signed three executive orders aimed at lowering the price of prescription drugs, with actions targeting federally qualified health center insulin and EpiPen discounts; the importation and re-importation of prescription drugs from foreign countries; and drug manufacturer rebates and…
Leaders of the Black Maternal Health Caucus virtually convened the second annual Stakeholder Summit, where members of Congress and supporting organizations urged passage of the Black Maternal Health Momnibus Act (H.R. 6142/S. 3424) to end preventable maternal mortality and severe maternal morbidity…
Saint Anthony Hospital, a safety-net hospital in Chicago, through its Community Wellness Programs has continued to provide free mental health services targeting minority and immigrant populations despite challenges due to COVID-19.
Atrium Health President and CEO Eugene Woods spoke on CBS’s Face the Nation about the lack of reagents for COVID-19 testing, racial disparities during the pandemic and treating thousands of COVID-19 patients in their homes.
Hologic Inc. received $7.6 million from the Department of Health and Human Services and Department of Defense to increase production of supplies needed for COVID-19 testing, including custom sample collection and processing consumables.
The National Institutes of Health announced that a COVID-19 vaccine candidate co-developed by Moderna, Inc. and the National Institute of Allergy and Infectious Diseases has begun a phase 3 clinical trial.